Last checked at 22 Oct 2021 16:05
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Scancell Holdings Share News (SCLP)
SCLP Share
Price
SCLP Share
News
SCLP Share
Chat42
SCLP Share
Trades8
SCLP
Live RNS
SCLP Share
Charts
SCLP Level 2
Console
SCLP Live
Share Price
SCLP Broker
Ratings
SCLP Directors
Deals
SCLP Financial
Diary
SCLP
Fundamentals
SCLP Short
Positions
SCLP
Media
Scancell Holdings Information
Share Price Information for Scancell Holdings (SCLP)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
9.60
Bid:
9.40
Ask:
9.80
Change:
0.00 (0.00%)
Spread:
0.40 (4.255%)
Open:
9.36
High:
9.60
Low:
9.36
Prev. Close:
9.60
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.19 Oct 2021 20:41
IN BRIEF: Scancell bases new facility at Oxford Science Park
IN BRIEF: Scancell bases new facility at Oxford Science Park
Read more5 Oct 2021 22:03
IN BRIEF: Scancell doses first subject in Covidity phase one trial
IN BRIEF: Scancell doses first subject in Covidity phase one trial
Read more26 Aug 2021 12:53
TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV
TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV
Read more26 Aug 2021 12:38
Scancell gets MHRA approval for Modi-1 clinical trial
(Sharecast News) - Immunotherapy developer Scancell announced on Thursday that the UK Medicines and Healthcare products Regulatory Authority (MHRA) has approved the clinical trial application to initiate the first-in-human phase 1 and 2 clinical study of 'Modi-1'.
Read more17 Aug 2021 15:32
Scancell chooses needle-free tech for Covid vaccine candidates
(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell has selected the PharmaJet needle-free injection system to administer its two SARS-CoV-2 vaccine candidates for Covid-19, 'SCOV1' and 'SCOV2', in its 'COVIDITY' phase 1 clinical trial, it announced on Tuesday.
Read more30 Jul 2021 14:24
DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares
DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares
Read more29 Jul 2021 22:08
TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook
TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook
Read more28 Jul 2021 22:00
IN BRIEF: Scancell turns once again to Durrant to lead company
IN BRIEF: Scancell turns once again to Durrant to lead company
Read more22 Jun 2021 15:21
Scancell makes progress with 'Covidity' trial plans
(Sharecast News) - Immunotherapy developer Scancell updated the market on 'Covidity' clinical trial plans, and the publication of preclinical data on two vaccine candidates from the research programme.
Read more22 Jun 2021 12:14
IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK
IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK
Read more7 Jun 2021 13:58
IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares
IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares
Read more7 Jun 2021 10:38
AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact
AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact
Read more30 Apr 2021 14:30
IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares
IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares
Read more19 Feb 2021 20:13
IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares
IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares
Read more